Skip to main content

Table 1 Reported outcomes

From: Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

Studies Reported outcomes Follow up period Types of patients
Gorst 2016 [8] Stroke/SE/TIA, any bleeding, death, intracranial bleeding, GI bleeding, venous thromboembolism 1 year -
Larock 2014 [9] Stroke/TIA, venous thromboembolism, any bleeding, death - NVAF
Maura 2015 [10] Bleeding events, ischemic stroke/SE 3 months NVAF
Providencia 2014 [11] Death, thromboembolism, stroke, TIA, SE, major bleeding, minor bleeding 30 days -
Sherid 2014 [12] Major bleeding other than GI bleeding, intracranial hemorrhage, stroke/TIA, venous thromboembolism, death, GI bleeding 40 days -
  1. Abbreviations: SE systemic embolism, TIA transient ischemic attack, GI gastrointestinal, NVAF non-valvular atrial fibrillation